Pacific Biosciences of California (PACB) PT Raised to $13 at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts PACB Hot Sheet
Price: $1.19 +3.48%
Rating Summary:
9 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
9 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Cantor Fitzgerald analyst Ross Osborn raised the price target on Pacific Biosciences of California (NASDAQ: PACB) to $13.00 (from $12.00) while maintaining a Neutral rating.
You May Also Be Interested In
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- Central Retail Corp PCL (CRC:TB) PT Lowered to THB9,000 at Macquarie
- Seazen Holdings Co Ltd (601155:CH) PT Lowered to RMB11 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
